Lalomia Brent 4

What Happened

• Brent Lalomia, Executive Vice President, Regulatory Affairs & Quality Assurance at ConMed Corporation (CNMD), had 75 vested restricted stock units (RSUs) settle on March 6, 2026. The RSUs converted into 75 shares of common stock (reported as derivative exercise/conversion).
• To cover withholding tax, 26 of those shares were surrendered/withheld at $39.90 per share, producing proceeds of about $1,037. The RSU settlement had no out‑of‑pocket purchase price (acquisition reported at $0), so Lalomia effectively received a net 49 shares.

Key Details

• Transaction date: March 6, 2026; Form 4 filed March 10, 2026 (timely — within the SEC’s two-business-day reporting window).
• Reported prices/values: 75 shares acquired via RSU settlement @ $0; 26 shares withheld for taxes @ $39.90 each (≈ $1,037 total).
• Shares owned after transaction: the filing does not state a final total in the provided summary; the filing notes the reporting person’s beneficial ownership was adjusted to exclude 140 shares that were incorrectly reflected in prior reports (Footnote F1).
• Footnotes: F2 confirms these were vested RSUs (each RSU = one share) settled with share delivery and withholding for taxes. F1 notes a prior reporting correction excluding 140 shares.
• Transaction codes: M = exercise/conversion of derivative (RSU settlement here); F = payment of tax liability via share withholding.

Context

• This was an RSU settlement with shares withheld to satisfy tax withholding — a routine, non‑market purchase/sale by an insider (not an open‑market trade). Because the insider did not buy shares with cash, this is generally considered administrative (compensation vesting) rather than a bullish purchase signal.
• The filing appears timely. The reduction of 140 previously reported shares (F1) is an administrative correction to prior reports and may affect comparisons of historical insider holdings.